Jan A J W Kluytmans Selected Research

Mupirocin (Bactroban)

10/2011	Eradication of carriage with methicillin-resistant Staphylococcus aureus: effectiveness of a national guideline.
10/2011	Eradication of carriage with methicillin-resistant Staphylococcus aureus: determinants of treatment failure.
1/2010	Preventing surgical-site infections in nasal carriers of Staphylococcus aureus.
8/2008	New approaches to prevention of staphylococcal infection in surgery.
2/2008	Intranasal mupirocin for reduction of Staphylococcus aureus infections in surgical patients with nasal carriage: a systematic review.
3/2004	Mupirocin prophylaxis against nosocomial Staphylococcus aureus infections in nonsurgical patients: a randomized study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jan A J W Kluytmans Research Topics

Disease

20	Infections 05/2022 - 03/2004
9	Surgical Wound Infection 10/2020 - 03/2004
4	Bacteremia 01/2020 - 07/2011
4	Pneumonia (Pneumonitis) 01/2017 - 07/2013
3	Wounds and Injuries (Trauma) 01/2019 - 08/2013
3	Staphylococcal Infections 08/2008 - 03/2004
3	Coronary Artery Disease (Coronary Atherosclerosis) 03/2005 - 07/2003
2	COVID-19 05/2022 - 01/2020
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2020 - 05/2014
2	Surgical Wound 08/2017 - 08/2013
2	Sepsis (Septicemia) 07/2013 - 07/2011
2	Foreign Bodies (Foreign Body) 10/2011 - 10/2011
2	Cross Infection (Nosocomial Infection) 01/2010 - 08/2008
2	Legionnaires' Disease (Legionnaire's Disease) 05/2006 - 03/2006
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 10/2020
1	Diabetes Mellitus 01/2018
1	Peripheral Arterial Disease 12/2014
1	Pain (Aches) 08/2013
1	Suppuration 08/2013
1	Respiratory Tract Infections (Respiratory Tract Infection) 04/2012
1	Chlamydophila Infections 03/2005
1	Cardiovascular Diseases (Cardiovascular Disease) 02/2005
1	Atherosclerosis 07/2003

Drug/Important Bio-Agent (IBA)

13	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 07/2003
6	Mupirocin (Bactroban)FDA LinkGeneric 10/2011 - 03/2004
4	Clarithromycin (Biaxin)FDA LinkGeneric 03/2005 - 07/2003
3	AntigensIBA 05/2022 - 07/2013
3	MacrolidesIBA 01/2020 - 07/2003
2	Azithromycin (Zithromax)FDA LinkGeneric 01/2020 - 05/2014
2	DNA (Deoxyribonucleic Acid)IBA 01/2007 - 05/2006
1	Cefotaxime (Kendrick)FDA LinkGeneric 01/2021
1	Third Generation CephalosporinsIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 11/2020
1	carbapenemaseIBA 07/2020
1	beta-Lactamases (beta-Lactamase)IBA 01/2020
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2020
1	Anti-Infective Agents (Microbicides)IBA 08/2017
1	beta-lactamase NDM-1IBA 01/2017
1	Cephalosporins (Cephalosporin Antibiotics)IBA 01/2015
1	LactamsIBA 07/2013
1	Ceftazidime (Fortum)FDA LinkGeneric 07/2013
1	ChlorhexidineIBA 01/2010
1	Vancomycin FDA LinkGeneric 08/2008
1	chlorhexidine gluconate (Dyna-Hex)FDA LinkGeneric 08/2008
1	ImmunosorbentsIBA 03/2006
1	Immunoglobulin M (IgM)IBA 03/2006
1	EnzymesIBA 03/2006
1	Immunoglobulin G (IgG)IBA 03/2006
1	TabletsIBA 11/2004

Therapy/Procedure

6	Vascular Surgical Procedures 10/2020 - 01/2012
4	Therapeutics 01/2020 - 07/2011
3	Length of Stay 07/2020 - 01/2017
3	Operative Surgical Procedures 01/2018 - 02/2008
2	Antibiotic Prophylaxis 01/2019 - 08/2008
1	Self-Testing 05/2022
1	Reoperation 12/2014
1	Punctures 08/2013
1	Catheters 07/2011
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 02/2005